April 9, 2015
Lower survival rates connected with high-risk melanoma with mutations, study finds
A UNC Lineberger-led study found that people with higher-risk melanoma containing either BRAF or NRAS gene mutations had lower survival rates.
Tag: Skin Cancer and Melanoma Clinical Program
February 16, 2015
UNC’s multidisciplinary melanoma conference draws health professionals from around NC
The ninth annual UNC Multidisciplinary Melanoma Conference brought more than 120 health care professionals from across the state on Thursday, February 12 to learn about the detection and treatment of melanoma.
October 22, 2014
UNC scientists discover hidden subpopulation of melanoma cells
The research, led by Andrew C. Dudley, has implications for developing cancer drugs that target blood vessels that feed tumors.
February 6, 2014
UNC Lineberger receives jointly awarded $1 million research grant to investigate novel target in melanoma
The $1 million award from the Melanoma Research Alliance and the Saban Family Foundation will support research to improve the treatment of melanoma, the most aggressive type of skin cancer.
August 26, 2013
Ollila appointed James H. and Jesse E. Millis Distinguished Professor
David Ollila, MD, professor of surgery, has been appointed to the James H. and Jesse E. Millis Distinguished Professorship. The $1.5 million professorship was established by their son, William (Bill) Millis in honor of his parents, Jim and Jesse Millis of High Point, N.C.
February 16, 2013
Carol Enarson
When former school nurse Carol Enarson of Chapel Hill learned she had melanoma, she was shocked. After all, as a school nurse at Forsyth Country Day School (FCDS) in Winston-Salem she had developed innovative sun safety programs for elementary school students. “It is best to teach sun safety early on and before they start thinking about tanning beds,” she says.
August 17, 2012
Study reveals new molecular target for melanoma treatment
Chapel Hill, NC – A laboratory study led by UNC medical oncologist Stergios Moschos, MD, demonstrates how a new targeted drug, Elesclomol, blocks oxidative phosphorylation, which appears to play essential role in melanoma that has not been well-understood.
June 14, 2012
Genetic pattern predicts response, metastasis in melanoma
A gene known to be mutated in many different cancers, but thought to be relatively unimportant in melanoma, may be a key indicator of how the disease will respond to radiation therapy and whether it will spread.
June 11, 2012
Gene inactivation drives spread of melanoma
Chapel Hill, NC – Why do some cancers spread rapidly to other organs and others don’t metastasize? A team of UNC researchers led by Norman Sharpless, MD, have identified a key genetic switch that determines whether melanoma, a lethal skin cancer, spreads by metastasis.
November 22, 2011
P Rex-1 protein key to melanoma metastasis
UNC scientists contribute cell studies and protein expression analysis